Literature DB >> 18306482

Irreversible paraplegia following one time prophylactic intrathecal chemotherapy in an adult patient with acute lymphoblastic leukemia.

Hea Yong Lee1, Sung-il Im, Myoung-Hee Kang, Kwang Min Kim, Seok Hyun Kim, Hun-Gu Kim, Jung Hun Kang, Gyeong-Won Lee.   

Abstract

We present an adult female patient who developed irreversible paraplegia and areflexia four days post intrathecal chemotherapy with methotrexate, cytosine arabinoside and hydrocortisone. On magnetic resonance imaging (MRI) of the lumbar spine, diffuse gadolinium enhancement of the anterior spinal nerve roots (ventral roots) was detected. Methylprednisolone was intravenously administered at a daily dose of 30mg/kg for three days. Despite this treatment, flaccid weakness in the lower extremities and urinary retention persisted. Following consolidation chemotherapy, no improvement in neurologic status was noted. Six months later, a follow-up MRI revealed severe atrophy of the thoracic spinal cord.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18306482      PMCID: PMC2615263          DOI: 10.3349/ymj.2008.49.1.151

Source DB:  PubMed          Journal:  Yonsei Med J        ISSN: 0513-5796            Impact factor:   2.759


  24 in total

1.  Magnetic resonance imaging findings in a case of cytarabine-induced myelopathy.

Authors:  Paul M Sherman; Clifford J Belden; Douglas A Nelson
Journal:  Mil Med       Date:  2002-02       Impact factor: 1.437

2.  Paraplegia following intrathecal methotrexate: report of a case and review of the literature.

Authors:  R G Gagliano; J J Costanzi
Journal:  Cancer       Date:  1976-04       Impact factor: 6.860

3.  Paraparesis following intrathecal cytosine arabinoside: a case report with neuropathologic findings.

Authors:  A C Breuer; S W Pitman; D M Dawson; W C Schoene
Journal:  Cancer       Date:  1977-12       Impact factor: 6.860

4.  Neurotoxicity and elevated cerebrospinal-fluid methotrexate concentration in meningeal leukemia.

Authors:  W A Bleyer; J C Drake; B A Chabner
Journal:  N Engl J Med       Date:  1973-10-11       Impact factor: 91.245

5.  Paraplegia following intrathecal methotrexate.

Authors:  R E Luddy; P A Gilman
Journal:  J Pediatr       Date:  1973-12       Impact factor: 4.406

6.  Paraplegia following intrathecal cytosine arabinoside.

Authors:  L Wolff; J Zighelboim; R P Gale
Journal:  Cancer       Date:  1979-01       Impact factor: 6.860

7.  Myelopathy due to intrathecal chemotherapy: report of six cases.

Authors:  Ali Bay; Ahmet Faik Oner; Omer Etlik; Cahide Yilmaz; Huseyin Caksen
Journal:  J Pediatr Hematol Oncol       Date:  2005-05       Impact factor: 1.289

8.  Encephalomyelopathy following intrathecal methotrexate treatment in a child with acute leukemia.

Authors:  K Skullerud; K Halvorsen
Journal:  Cancer       Date:  1978-09       Impact factor: 6.860

9.  Necrotizing myelopathy associated with acute lymphoblastic leukemia. Case report and review of literature.

Authors:  W Grisold; D Lutz; D Wolf
Journal:  Acta Neuropathol       Date:  1980       Impact factor: 17.088

10.  Central and peripheral myelinopathy associated with systemic neoplasia and chemotherapy.

Authors:  H Mena; J H Garcia; F Velandia
Journal:  Cancer       Date:  1981-10-15       Impact factor: 6.860

View more
  1 in total

1.  A case of the cauda equina syndrome associated with the intrathecal chemotherapy in a patient with primary central nervous system lymphoma.

Authors:  Seunglee Park; Jung-Il Kang; Hyun Bang; Bo-Ram Kim; Jongmin Lee
Journal:  Ann Rehabil Med       Date:  2013-06-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.